The breakthrough is another major step forward on the journey to develop a commercially viable drug version based on teixobactin — a natural antibiotic discovered by US scientists in soil samples in 2015 which has been heralded as a «gamechanger» in the
battle against antibiotic resistant
pathogens such as MRSA and VRE.